WallStreetZenWallStreetZen

NASDAQ: APRE
Aprea Therapeutics Inc Stock Ownership - Who owns Aprea Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Aprea Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Marc DueyDirector2025-12-1021,459$1.17
$25.00kBuy
John P. HamillSrVPCFOPrin Fin Acct Ofcr2025-12-105,000$1.17
$5.83kBuy
Oren GiladPresidentCEO2025-04-033,003$1.87
$5.62kBuy
Oren GiladPresidentCEO2025-04-032,497$1.80
$4.49kBuy

1 of 1

APRE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when APRE insiders and whales buy or sell their stock.

APRE Shareholders

What type of owners hold Aprea Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Tryant LLC443.69%28,000,000$25.48MInsider
Thomas Banks212.20%13,391,146$12.19MInsider
Frank J. Hall75.77%4,781,889$4.35MInsider
David West Wilson46.35%2,924,726$2.66MInsider
Heidi A. Patterson42.60%2,688,221$2.45MInsider
Kdev Investments Ab31.57%1,992,586$1.81MInsider
Michael Reynolds31.38%1,980,040$1.80MInsider
Redmile Group LLC28.03%1,768,718$1.61MInsider
Aigh Capital Management LLC8.55%539,300$490.76kInstitution
Oren Gilad5.51%347,420$316.15kInsider

1 of 3

APRE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
APRE2.65%97.35%Net BuyingNet Buying
CELZ2.74%1.37%Net Selling
CYCN6.59%72.50%Net Buying
TOVX1.30%0.74%
IMRN0.03%0.00%
View Top Biotech Stocks

Aprea Therapeutics Stock Ownership FAQ

Who owns Aprea Therapeutics?

Aprea Therapeutics (NASDAQ: APRE) is owned by 25.65% institutional shareholders, 941.58% Aprea Therapeutics insiders, and 0.00% retail investors. Tryant LLC is the largest individual Aprea Therapeutics shareholder, owning 28.00M shares representing 443.69% of the company. Tryant LLC's Aprea Therapeutics shares are currently valued at $25.48M.

If you're new to stock investing, here's how to buy Aprea Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.